3-O-ETHYL ASCORBIC ACID: WHAT THE PUBLISHED DATA MEASURED
One double-blind RCT and two controlled published studies. 911 subjects in total. Measured with spectrophotometry, cutometry and multispectral imaging. Below is what the instruments recorded, stat by stat, with the source named for each and the formula each figure belongs to. Vector ONE carries it at 6% in a night cream.
Skin loses collagen as it ages, and sunlight speeds the loss. Building collagen depends on vitamin C being on hand: run short of it and the process that firms skin runs slow. Sun exposure also spends what is there, and reserves fall with age on their own. Published measurements found sun-aged skin holding only 69% of the vitamin C in its outer layer and 63% in the deeper layer compared with young, protected skin. Naturally aged skin showed a similar decline: 61% outer, 70% deeper. Diet alone does not refill it fast enough.
The obvious answer is to apply Vitamin C topically. The problem: pure L-ascorbic acid is violently unstable. It oxidizes on contact with air, degrades in heat, and requires a pH below 3.5 to penetrate your skin. That acidity destroys the skin barrier, causes stinging and redness, and drives most people to quit within weeks. The molecule you need is too fragile to survive the bottle and too corrosive to survive your face.
The fix is a form of vitamin C that survives the bottle and still converts to usable vitamin C once it is in the skin. No degradation on the shelf. The amount on the label is the amount that goes on your face.
EAA gets around the limits of pure vitamin C. It is stable in the bottle, compatible with your skin's own pH, moves through both oily and watery layers, and converts to vitamin C in the skin. Molecular weight: 204.18 Da. Vitamin C equivalence: 84-86%. Stability pH range: 3.0 to 6.0.
This is the largest published RCT on any vitamin C derivative complex for the look of uneven pigment. The 850-subject cohort was deliberately weighted toward Fitzpatrick skin types III through VI, the deeper, melanin-rich tones most prone to the dark marks left behind after blemishes or irritation. The formulation combined a proprietary 3-O-Ethyl Ascorbic Acid complex with 2% niacinamide, salicylic acid, and a specialized licorice root extract (CL-302 Complex), applied twice daily across the study's 16 weeks. Results reflect the full multi-active formula, not EAA in isolation.
The headline number (52% melanin index reduction) was measured with multispectral imaging at the dermal-epidermal junction, so it is not a surface reading: it reflects a genuine drop in melanin clustering below the surface. The 68% reduction in stubborn dark marks among the blemish-prone subjects came from that same complete formula. Separately, a benchtop test run in a dish rather than on skin recorded 58% less pigment formed by the EAA component. No redness. No barrier disruption. No paradoxical darkening.
| Melanin index reduction (16 wk) | 52% |
| Dark marks after blemishes, blemish-prone subset | 68% |
| Pigment formed in a benchtop lab test (not on skin) | 58% |
| Tolerability (no redness or barrier disruption) | Confirmed |
| Formulation | Multi-active (EAA + niacinamide + SA + licorice) |
This trial used a 10% 3-O-Ethyl Ascorbic Acid serum applied daily for 28 days and measured the results with the Cutometer Dual MPA 580, a suction-based instrument that quantifies the actual viscoelastic properties of skin. This is not a self-assessment survey. This is a machine physically pulling on skin and measuring how it responds.
A 15.19% increase in R5 (net elasticity) inside the study's 28 days points to measurable change below the surface from that 10% EAA formulation, not just a coat of something on top. Part of that fast firming may also be quick surface hydration. Alongside it, pore size dropped 9.86% and overall brightness rose 4.49%. Zero adverse effects were recorded at that study's 10% concentration, which suggests a wide margin at lower ones.
Skin needs vitamin C on hand to build collagen properly. Short of it, what gets built is weaker and goes sooner. EAA is in Vector ONE to keep that supply topped up, in a form that survives the bottle. The 20.35% firmness gain recorded over the 28 days of the 10% study is what that looked like on an instrument, in that study's formula.
| Skin firmness (gross) | +20.35% |
| Net elasticity R5 | +15.19% |
| Biological elasticity R7 | +11.55% |
| Gross elasticity R2 | +3.08% |
| Wrinkle depth | -13.71% |
| Pore size | -9.86% |
| Skin brightness (L*) | +4.49% |
An 8% ITA° improvement over 8 weeks is a real, visibly obvious tonal shift.
The 13% drop in colour intensity of isolated dark spots, paired with a 6% drop in their physical size, says the spots themselves got lighter and smaller rather than the whole face picking up a brightening haze. That came from three ingredients carried in one formula: EAA, tranexamic acid and niacinamide. It cannot be split between them, and we are not going to pretend otherwise. Tolerability was exceptional: 95% of participants reported improved hydration and skin comfort.
| Dark spot color intensity | -13% |
| Dark spot physical size | -6% |
| Tissue luminosity (L*) | +1% absolute |
| Individual Typological Angle (ITA°) | +8% |
| Self-reported comfort improvement | 95% |
Your instinct says more is better. The permeation data says otherwise. When EAA is dissolved in simple neat solvents (pure propylene glycol, glycerol, or 1,2-hexanediol), the cumulative 24-hour permeation through full-thickness skin ranges from a dismal 0.6% to 7.5% of the applied amount. Common penetration enhancers like Transcutol gave surface uptake but nothing measurable reaching deeper layers. Which means a high-percentage EAA in a bad vehicle can put less into the skin than a lower percentage in a properly engineered one.
The breakthrough came from ternary solvent systems. Work using Franz diffusion cells on full-thickness porcine skin in the lab showed that combining propylene glycol (PG) with propylene glycol monolaurate (PGML) and isopropyl myristate (IPM) creates an optimal thermodynamic driving force. This PG:PGML:IPM system moved 70.9% of the applied EAA over 24 hours in that lab model. Absorption on living human skin will differ, since blood flow and a living barrier change the picture, but the relative advantage of an optimised vehicle over a simple solvent holds. PG increases solubility in the superficial stratum corneum. PGML fluidizes the lipid domains. IPM creates transient microscopic channels through the barrier.
Concentration is meaningless without delivery. A 6% EAA formula in an optimized amphiphilic vehicle system can outperform a 30% formula in a basic aqueous base. The strongest published results (20.35% firmness gain at 10% EAA, 52% melanin reduction in a multi-active complex) were achieved with engineered delivery matrices, not brute-force concentration. The dose that matters is the dose that reaches the cell.
"The optimized PG:PGML:IPM ternary vehicle was shown to promote an unprecedented 70.9% transdermal delivery of the applied EAA dose over 24 hours."
MDPI Scientia Pharmaceutica - Permeation study, porcine skin lab modelThe studies above ran from 28 days to 16 weeks. Those are the lengths of the studies, not a timetable for your face. The formulation below is what those principles look like in a bottle.
SATURATE Vector ONE
Vector ONE is not a vitamin C serum. It is a night cream carrying EAA at 6% in an amphiphilic vehicle built around how much of it actually gets in. The studies all point the same way: the ones that moved a number paired their concentration with delivery rather than brute force. The strongest published EAA-alone study used 10% and recorded a 20.35% firmness gain over its 28 days. At 6%, Vector ONE trades a little of that for something you can use every night, putting 3-O-Ethyl Ascorbic Acid into the viable epidermis rather than leaving it sitting on the surface.
